Patent · US Active

Compounds and their methods of use

US9029531B2 · kind B2 · utility

7Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2013
Grant dateMay 12, 2015
Priority date
Expiry dateNov 21, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D285/135
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that inhibit glutaminase in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.